<?xml version="1.0" encoding="UTF-8"?>
<p>Preclinical evidence. This herbal medicine has not been experimentally proven for the symptoms of respiratory disease. However, procyanidins present in small flowers were evaluated about an inflammatory response in human neutrophils in the concentration ranging from 5 to 20 μM. All compounds were able to decrease ROS production from f-MLP-stimulated neutrophils. Most compounds were able to inhibit LPS-induced IL-8 release. Some trimeric and tetrameric derivatives were also able to decrease the production of MIP-1β. A hydromethanolic extract presented anti-inflammatory and antinociceptive activities in rats, in a similar way than indomethacin and acetylsalicylic acid, respectively (
 <xref rid="B182" ref-type="bibr">Fawzy et al., 2018</xref>).
</p>
